While South Korea's flagship KOSPI index is in turmoil after a massive crash, stocks of small and mid-cap companies on the KOSDAQ exchange are showing impressive gains. Shares of HLB, SPG, and Peptron have risen more than 50% over the past month, sharply contrasting with overall market dynamics.
This capital shift appears to be a natural reaction to the tightening of regulatory requirements for leveraged ETFs by authorities in late July. Amid a global sell-off of chipmaker stocks triggered by cooling interest in artificial intelligence, investors have begun massively withdrawing funds from KOSPI "blue chips" and moving them into smaller but promising companies on KOSDAQ.
Failure of Giants and Revival of Outsiders
July became one of the worst months in KOSPI history: the index lost 22%, and from its peak on July 22, the drawdown reached 34%. Although the last trading session of the month brought nearly 18% growth, it only partially compensated for the scale of losses. The main culprits of the crash were leveraged ETFs tracking shares of Samsung Electronics and SK Hynix. Regulators were forced to raise the minimum deposit for trading these instruments from 10 to 30 million won (KRW), leading to a 93% collapse in trading volumes.
However, instead of the expected stabilization, we are witnessing a curious effect: capital has flowed in the opposite direction. The KOSDAQ index rose for five consecutive trading days until August 6, ignoring KOSPI's volatility. The decline of tech giants is particularly telling: SK Hynix shares plunged 14.65% on July 28, while Samsung Electronics lost more than 13% amid fears that investments in AI infrastructure have peaked. Micron's 39% crash only added pressure on Korean memory manufacturers.
Fundamental Growth Drivers
The growth of each of the three companies has its own unique catalysts. HLB shares jumped nearly 30% in a single day after the FDA lifted restrictions on a Chinese partner's plant, although it had previously denied approval of the anticancer drug rivoceranib three times due to production issues.
SPG, a manufacturer of high-precision motors and reducers, is steadily rising thanks to its actuator project for humanoid robots. According to IBK Securities estimates, it is the only Korean company with a full range of high-precision reducers for humanoid robots. It already supplies products to Rainbow Robotics and is in preliminary talks with American partners.
Peptron has gained on rumors of possible involvement in the supply chain of anti-obesity drugs. Investors believe Korean manufacturers could take on production for the domestic market of Eli Lilly's monthly GLP-1-based drug, although an official contract has not yet been signed.
My view: This rotational shift is not just a temporary flight from risk, but a signal of value reassessment. While semiconductor giants consolidate after overheating, investors are seeking new growth stories in biotech and robotics. However, it is worth remembering that such rallies on KOSDAQ are often speculative in nature, and without confirmation of fundamental indicators, the correction could be just as swift as the surge.